S-(2-boronoethyl)-L-cysteine has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Oct 23, 2026: “Removing a gene reduced age-related bone loss in mice”.
1 paper studies it2 findingsUpdated
1 new paper in 30 daysSee all 1
None of its findings points the other way.
Studies of S-(2-boronoethyl)-L-cysteine measured 2 outcomes; the most studied are age-associated osteoporosis (1 study) and cellular senescence (1).
Age-associated osteoporosis
downin mice1
S-(2-boronoethyl)-L-cysteine protects against age-associated osteoporosis in mice.
“pharmacological inhibition of ARG2 using S-(2-boronoethyl)-L-cysteine (BEC) significantly suppressed osteoblast senescence and protected against age-related osteoporosis.”
Animalsbone
Removing a gene reduced age-related bone loss in mice
Theranostics
Cellular senescence
downin mouse cells1
S-(2-boronoethyl)-L-cysteine decreases cellular senescence in mouse cells.
“pharmacological inhibition of ARG2 using S-(2-boronoethyl)-L-cysteine (BEC) significantly suppressed osteoblast senescence and protected against age-related osteoporosis.”
Cellsosteoblast
Removing a gene reduced age-related bone loss in mice
Theranostics
In experiments with 12 mice per group, deleting the gene in bone-building cells reduced bone loss after 12 weeks of chemically induced aging.In experiments with 12 mice per group, deleting the gene in bone-building cells reduced bone loss after 12 weeks of chemically induced aging.